242.960 -

-7.890 (-3.15%)
价格区间 241.450 - 254.395   (5.36%)
开盘 251.850
昨收 250.850
242.990
买盘 15
243.040
卖盘 400
成交量 609,793
成交额 108,380,228
注释 -
数据延迟。最后一次更新13 Feb 2026 04:30.
数据提供商
查看所有活动

关于 Insulet

Insulet Corporation is engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (the OmniPod System). The OmniPod System is an insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the Company's handheld, wireless Personal Diabetes Manager (PDM). The OmniPod Insulin Management System is designed to provide people with insulin-dependent diabetes with a diabetes management solution which provides lifestyle and other benefits and to expand the use of continuous subcutaneous insulin infusion (CSII) therapy. The OmniPod operates up to 72 hours (but no more than 80 hours) after it is activated.

There are 8 follower

粉丝
0
粉丝
0
粉丝
2
粉丝
1
粉丝
0
粉丝
0
粉丝
0